1 Ocak 2022 Dergi makalesi Açık Erişim

Kurter, Hasan; Mert-Ozupek, Nazli; Ellidokuz, Hulya; Calibasi-Kocal, Gizem

JSON-LD (schema.org)

{
  "@context": "https://schema.org/", 
  "@id": 254415, 
  "@type": "ScholarlyArticle", 
  "creator": [
    {
      "@type": "Person", 
      "affiliation": "Dokuz Eylul Univ, Inst Hlth Sci, Dept Translat Oncol, Izmir, Turkey", 
      "name": "Kurter, Hasan"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Dokuz Eylul Univ, Inst Hlth Sci, Dept Basic Oncol, Izmir, Turkey", 
      "name": "Mert-Ozupek, Nazli"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Dokuz Eylul Univ, Inst Oncol, Dept Prevent Oncol, Izmir, Turkey", 
      "name": "Ellidokuz, Hulya"
    }, 
    {
      "@type": "Person", 
      "affiliation": "Dokuz Eylul Univ, Inst Oncol, Dept Translat Oncol, Izmir, Turkey", 
      "name": "Calibasi-Kocal, Gizem"
    }
  ], 
  "datePublished": "2022-01-01", 
  "description": "Background The aim of the study was in-silico drug-likeness analysis, absorption, distribution, metabolism, and excretion (ADME) properties, and molecular docking studies of anthocyanins as natural anticancer compounds against acting receptor-like kinase 5 (ALK5) receptor. Transforming growth factor-beta (TGF-beta) plays an essential role in various cellular processes. Increased expression of TGF-beta and its receptor TGF beta R-I (i.e. ALK5) have been associated with poor prognosis in cancer patients. Methods The drug-likeness activity of anthocyanins was performed using SwissADME tool. Molecular docking studies were carried out by using the Autodock Vina 1.5.6 tool. Results The results revealed that cyanidin-3-arabinoside (C3A), pelargonidin-3-glucoside (P3G), and peonidin-3-arabinoside (P3A) were able to use both Lipinski's rule of five and Ghose variations. The binding energies of C3A, P3G, and P3A against ALK5 were found as -8.0, -8.3, and -8.4 kcal mol(-1), respectively. Conclusion These selected anthocyanins have shown higher binding energies than known inhibitors to the ALK5 receptor. Further in-vitro and in-vivo studies were strongly recommended to clarify the whole mechanism.", 
  "headline": "In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor", 
  "identifier": 254415, 
  "image": "https://aperta.ulakbim.gov.tr/static/img/logo/aperta_logo_with_icon.svg", 
  "license": "http://www.opendefinition.org/licenses/cc-by", 
  "name": "In-silico drug-likeness analysis, ADME properties, and molecular docking studies of cyanidin-3-arabinoside, pelargonidin-3-glucoside, and peonidin-3-arabinoside as natural anticancer compounds against acting receptor-like kinase 5 receptor", 
  "url": "https://aperta.ulakbim.gov.tr/record/254415"
}